Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#1 / 100 Total
NTNX - Nutanix Inc - Stock Price Chart
TickerNTNX [NASD]
CompanyNutanix Inc
CountryUSA
IndustrySoftware - Infrastructure
Market Cap13.18BEPS (ttm)-0.08
P/E-EPS this Y103.30%
Forward P/E38.06EPS next Y15.06%
PEG-EPS past 5Y9.62%
P/S6.29EPS next 5Y49.30%
P/B-EPS Q/Q78.99%
Dividend-Sales Q/Q16.94%
Insider Own0.39%Inst Own83.20%
Insider Trans-16.94%Inst Trans0.64%
Short Float2.56%EarningsMay 29/a
Analyst Recom1.62Target Price75.02
Avg Volume2.55M52W Range26.47 - 73.69
Nutanix, Inc. engages in the provision of a cloud platform leveraging web-scale engineering and consumer-grade design. It operates through the following geographic segments: United States, Europe, the Middle East, Africa, Asia Pacific, and Other Americas. The firm also provides software solutions and cloud services to customers' enterprise infrastructure. The company was founded by Dheeraj Pandey, Ajeet Singh, and Mohit Aron in 2009 and is headquartered in San Jose, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
RAMASWAMI RAJIVPresident and CEOJun 18 '24Sale54.1923,9861,299,738407,045Jun 18 09:50 PM
Sivaraman RukminiChief Financial OfficerJun 18 '24Sale53.2212,566668,788144,902Jun 18 09:47 PM
Sangster DavidChief Operating OfficerJun 18 '24Sale54.1910,384562,66064,333Jun 18 09:49 PM
Wall TylerChief Legal OfficerJun 15 '24Option Exercise0.0016,826029,994Jun 18 09:47 PM
Sivaraman RukminiChief Financial OfficerJun 15 '24Option Exercise0.0026,0250170,660Jun 18 09:47 PM
ADCT - Adc Therapeutics SA - Stock Price Chart
TickerADCT [NYSE]
CompanyAdc Therapeutics SA
CountrySwitzerland
IndustryBiotechnology
Market Cap261.75MEPS (ttm)-2.76
P/E-EPS this Y35.76%
Forward P/E-EPS next Y16.41%
PEG-EPS past 5Y84.52%
P/S3.81EPS next 5Y15.80%
P/B-EPS Q/Q23.23%
Dividend-Sales Q/Q-4.94%
Insider Own20.15%Inst Own40.27%
Insider Trans-0.32%Inst Trans4.65%
Short Float1.28%EarningsMay 06/b
Analyst Recom1.43Target Price10.00
Avg Volume600.55K52W Range0.36 - 6.04
ADC Therapeutics SA is a clinical-stage biotechnology company. It engages in the research and development and commercialization of targeted antibody drug conjugates for patients with hematological malignancies and solid tumors. Its clinical-stage product candidates include loncastuximab tesirine, camidanlumab tesirine, and ADCT-602. The company was founded by Christopher Martin on June 6, 2011 and is headquartered in Epalinges, Switzerland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sandor VictorDirectorJun 17 '24Sale2.896,99520,21680,886Jun 18 09:37 PM
Squarer RonDirectorJun 17 '24Sale2.896,99520,21680,663Jun 18 09:35 PM
BIZZARI JEAN-PIERREDirectorJun 17 '24Sale2.896,99520,21679,502Jun 18 09:43 PM
Azelby RobertDirectorJun 17 '24Sale2.896,99520,21653,005Jun 18 09:45 PM
Monges VivianeDirectorJun 17 '24Sale2.891,4374,153106,627Jun 18 09:40 PM
EXFY - Expensify Inc - Stock Price Chart
TickerEXFY [NASD, RUT]
CompanyExpensify Inc
CountryUSA
IndustrySoftware - Application
Market Cap110.57MEPS (ttm)-0.48
P/E-EPS this Y2895.74%
Forward P/E6.11EPS next Y16.99%
PEG-EPS past 5Y-
P/S0.77EPS next 5Y-
P/B1.04EPS Q/Q38.93%
Dividend-Sales Q/Q-16.37%
Insider Own47.06%Inst Own35.49%
Insider Trans-0.71%Inst Trans-1.51%
Short Float4.79%EarningsMay 09/a
Analyst Recom2.67Target Price2.75
Avg Volume504.77K52W Range1.24 - 8.25
Expensify, Inc. engages in the provision of a cloud-based expense management software platform that helps the smallest to the largest businesses simplify the way they manage money. It operates under the United States and All Other Locations geographical segments. The company was founded by David Barrett and Witold Stankiewicz on May 1, 2008 and is headquartered in Portland, OR.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Barrett David MichaelChief Executive OfficerJun 18 '24Sale1.3018,73024,3492,007,827Jun 18 09:44 PM
Barrett David MichaelChief Executive OfficerJun 17 '24Sale1.3717,94024,5782,026,557Jun 18 09:44 PM
Barrett David MichaelChief Executive OfficerJun 17 '24Sale1.3411,07214,836218,680Jun 18 09:44 PM
Muralidharan AnuradhaChief Operating OfficerJun 17 '24Sale1.342,6823,59460,347Jun 18 09:44 PM
Schaffer RyanChief Financial OfficerJun 17 '24Sale1.342,4433,274144,635Jun 18 09:45 PM
MDGL - Madrigal Pharmaceuticals Inc - Stock Price Chart
TickerMDGL [NASD, RUT]
CompanyMadrigal Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap5.88BEPS (ttm)-23.08
P/E-EPS this Y-42.98%
Forward P/E-EPS next Y37.25%
PEG-EPS past 5Y-55.24%
P/S-EPS next 5Y0.00%
P/B6.45EPS Q/Q-74.47%
Dividend-Sales Q/Q-
Insider Own17.75%Inst Own96.84%
Insider Trans-6.89%Inst Trans-1.64%
Short Float29.83%EarningsMay 07/b
Analyst Recom1.44Target Price365.07
Avg Volume494.13K52W Range119.76 - 299.98
Madrigal Pharmaceuticals, Inc. engages on the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product, MGL-3196, is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. The company was founded by Rebecca Taub and Edward Chiang on September 2011 and is headquartered in Fort Washington, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Waltermire Robert E.Senior VP, Chief Pharma Dev.Jun 14 '24Option Exercise87.091,900165,4717,400Jun 18 09:39 PM
Waltermire Robert E.Senior VP, Chief Pharma Dev.Jun 14 '24Sale280.001,900532,0005,500Jun 18 09:39 PM
Waltermire Robert E.Senior VP, Chief Pharma Dev.Jun 12 '24Option Exercise87.922,000175,8407,500Jun 14 09:44 PM
Waltermire Robert E.Senior VP, Chief Pharma Dev.Jun 12 '24Sale285.002,000570,0005,500Jun 14 09:44 PM
Waltermire Robert E.Senior VP, Chief Pharma Dev.May 21 '24Sale231.341,036239,6685,500May 23 09:36 PM
NTRA - Natera Inc - Stock Price Chart
TickerNTRA [NASD]
CompanyNatera Inc
CountryUSA
IndustryDiagnostics & Research
Market Cap13.26BEPS (ttm)-3.13
P/E-EPS this Y34.89%
Forward P/E-EPS next Y51.49%
PEG-EPS past 5Y-11.28%
P/S10.97EPS next 5Y-
P/B16.62EPS Q/Q54.33%
Dividend-Sales Q/Q52.11%
Insider Own6.03%Inst Own95.04%
Insider Trans-16.61%Inst Trans1.74%
Short Float4.94%EarningsMay 09/a
Analyst Recom1.47Target Price122.21
Avg Volume1.21M52W Range36.90 - 117.23
Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT). The company was founded by Matthew Rabinowitz and Jonathan Sheena in November 2003 and is headquartered in Austin, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Chapman Steven LeonardCEO AND PRESIDENTJun 17 '24Sale111.616,105681,372213,351Jun 18 09:35 PM
Marcus Gail BoxerDirectorMay 30 '24Sale110.172,000220,33018,634May 31 09:05 PM
Chapman Rowan EDirectorMay 28 '24Sale109.094,856529,7285,005May 30 09:05 PM
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICSMay 28 '24Sale109.961,647181,103114,186May 30 09:05 PM
Fesko JohnPRESIDENT, CHIEF BUS. OFFICERMay 28 '24Sale109.961,438158,122109,940May 30 09:05 PM
BTAI - BioXcel Therapeutics Inc - Stock Price Chart
TickerBTAI [NASD, RUT]
CompanyBioXcel Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap45.79MEPS (ttm)-5.18
P/E-EPS this Y57.92%
Forward P/E-EPS next Y33.87%
PEG-EPS past 5Y-35.97%
P/S26.02EPS next 5Y-
P/B-EPS Q/Q52.96%
Dividend-Sales Q/Q182.52%
Insider Own21.86%Inst Own24.92%
Insider Trans-3.13%Inst Trans-4.57%
Short Float5.05%EarningsMay 09/b
Analyst Recom1.80Target Price6.30
Avg Volume510.86K52W Range1.24 - 20.16
BioXcel Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of artificial intelligence solutions in neuroscience and immuno-oncology. It also focuses on utilizing technology and research to develop therapeutics solutions. The company was founded by Vimal D. Mehta on March 29, 2017 and is headquartered in New Haven, CT.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Mehta VimalCEO and PresidentJun 17 '24Sale1.282,1342,73947,539Jun 18 09:24 PM
Yocca FrankChief Scientific OfficerJun 17 '24Sale1.2837247613,474Jun 18 09:27 PM
Steinhart Richard IChief Financial OfficerJun 17 '24Sale1.263724705,476Jun 18 09:26 PM
Rodriguez JavierSee RemarksJun 17 '24Sale1.263614568,394Jun 18 09:25 PM
Wiley Matthew T.Chief Commercial OfficerJun 17 '24Sale1.262443083,498Jun 18 09:26 PM
JOBY - Joby Aviation Inc - Stock Price Chart
TickerJOBY [NYSE, RUT]
CompanyJoby Aviation Inc
CountryUSA
IndustryAirports & Air Services
Market Cap3.54BEPS (ttm)-0.75
P/E-EPS this Y8.30%
Forward P/E-EPS next Y9.74%
PEG-EPS past 5Y-
P/S3341.70EPS next 5Y-11.81%
P/B3.62EPS Q/Q25.99%
Dividend-Sales Q/Q-
Insider Own46.49%Inst Own30.85%
Insider Trans-0.38%Inst Trans0.23%
Short Float20.83%EarningsMay 07/a
Analyst Recom2.43Target Price7.67
Avg Volume4.34M52W Range4.50 - 11.98
Joby Aviation, Inc. is a transportation company, which engages in developing an all-electric, vertical take-off and landing aircraft that intends to operate as a commercial passenger aircraft. The company was founded by Bevirt Joebenn in 2009 and is headquartered in Santa Cruz, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Papadopoulos DidierPresident of Aircraft OEMJun 18 '24Sale4.923,26716,07477,854Jun 18 09:06 PM
Papadopoulos DidierPresident of Aircraft OEMJun 17 '24Sale4.934,21720,79081,121Jun 18 09:06 PM
Saluja DipenderDirectorJun 14 '24Option Exercise0.0022,5560102,603Jun 18 09:06 PM
Hoffman ReidDirectorJun 14 '24Option Exercise0.0022,5560102,603Jun 18 09:06 PM
Evans AichaDirectorJun 14 '24Option Exercise0.0022,556087,447Jun 18 09:05 PM
APPF - Appfolio Inc - Stock Price Chart
TickerAPPF [NASD, RUT]
CompanyAppfolio Inc
CountryUSA
IndustrySoftware - Application
Market Cap8.39BEPS (ttm)2.07
P/E111.72EPS this Y133.00%
Forward P/E44.82EPS next Y29.80%
PEG4.47EPS past 5Y-33.29%
P/S12.49EPS next 5Y25.00%
P/B24.73EPS Q/Q206.41%
Dividend-Sales Q/Q37.71%
Insider Own40.81%Inst Own54.29%
Insider Trans-1.74%Inst Trans0.13%
Short Float4.77%EarningsApr 25/a
Analyst Recom1.44Target Price266.60
Avg Volume303.25K52W Range162.32 - 256.73
AppFolio, Inc., provides industry-specific cloud-based business software solutions, services, and data analytics for the real estate industry. The firm offers AppFolio Property Manager, a property management solution designed to address the operational and business requirements of property management companies and their business ecosystems and AppFolio Investment Management, a cloud-based software solution for real estate investment managers of various sizes that provides tools and services designed to streamline their real estate investment management businesses. It also provides Value+ services that are designed to enhance, automate, and streamline processes and workflows for property management businesses, such as artificial intelligence leasing assistant, tenant screening, electronic payment, utility management, maintenance contact center, tenant debt collection, and mailing services. The company was founded by Brian Donahoo, Klaus Schauser and Jonathan Walker in 2006 and is headquartered in Santa Barbara, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DUCA MAURICE J10% OwnerJun 18 '24Sale231.972,750637,90449,650Jun 18 09:02 PM
DUCA MAURICE J10% OwnerJun 17 '24Sale229.652,600597,09852,400Jun 18 09:02 PM
KERR JANETDirectorJun 14 '24Sale232.332,500580,81813,180Jun 18 05:03 PM
DUCA MAURICE J10% OwnerJun 14 '24Sale231.202,100485,52655,000Jun 18 09:02 PM
BLISS TIMOTHY KDirectorJun 12 '24Sale241.3112,1702,936,8000Jun 13 07:27 PM
FLEX - Flex Ltd - Stock Price Chart
TickerFLEX [NASD]
CompanyFlex Ltd
CountryUSA
IndustryElectronic Components
Market Cap12.70BEPS (ttm)2.30
P/E13.75EPS this Y10.79%
Forward P/E11.43EPS next Y16.14%
PEG1.23EPS past 5Y67.12%
P/S0.45EPS next 5Y11.20%
P/B2.42EPS Q/Q200.39%
Dividend0.00%Sales Q/Q-17.49%
Insider Own0.88%Inst Own100.86%
Insider Trans-26.80%Inst Trans0.61%
Short Float2.82%EarningsMay 01/b
Analyst Recom1.73Target Price33.93
Avg Volume4.08M52W Range16.83 - 34.12
Flex Ltd. operates as a manufacturing services company. It delivers technology innovation, supply chain, and manufacturing solutions to diverse industries and end markets. The firm operates through the following segments: Flex Agility Solutions (FAS) and Flex Reliability Solutions (FRS). The Flex Agility Solutions segment consists of Communications, Enterprise and Cloud (CEC), including data infrastructure, edge infrastructure and communications infrastructure, Lifestyle, including appliances, consumer packaging, floorcare, micro mobility and audio and, Consumer Devices including mobile and high velocity consumer devices. The Flex Reliability Solutions segment consists of Automotive, including autonomous, connectivity, electrification, and smart technologies, Health Solutions, including medical devices, medical equipment and drug delivery, Industrial, including capital equipment, industrial devices, and Renewable, including NEXTracker business, grid edge, and power systems. The company was founded by Joe McKenzie and Barbara-Ann McKenzie in 1969 and is headquartered in Austin, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Advaithi RevathiChief Executive OfficerJun 17 '24Sale31.3037,1701,163,4212,057,473Jun 18 08:37 PM
Tan Kwang HooiGroup PresidentJun 17 '24Sale31.3013,451420,998183,496Jun 18 08:40 PM
Lundstrom PaulChief Financial OfficerJun 17 '24Sale31.307,895247,102346,943Jun 18 08:38 PM
Hartung Michael PGroup PresidentJun 17 '24Sale31.307,037220,263209,958Jun 18 08:37 PM
OFFER DAVID SCOTTEVP, General CounselJun 17 '24Sale31.307,037220,245171,344Jun 18 08:39 PM
ANAB - AnaptysBio Inc - Stock Price Chart
TickerANAB [NASD, RUT]
CompanyAnaptysBio Inc
CountryUSA
IndustryBiotechnology
Market Cap625.35MEPS (ttm)-6.13
P/E-EPS this Y2.97%
Forward P/E-EPS next Y-6.82%
PEG-EPS past 5Y-19.45%
P/S27.24EPS next 5Y-
P/B13.09EPS Q/Q-3.54%
Dividend-Sales Q/Q422.49%
Insider Own11.26%Inst Own97.87%
Insider Trans-5.36%Inst Trans4.78%
Short Float18.54%EarningsMay 09/a
Analyst Recom1.60Target Price43.78
Avg Volume365.46K52W Range13.36 - 27.50
AnaptysBio, Inc. is a clinical stage biotechnology company. engages in the development of antibody product candidates. Its products pipeline include ANB030, ANB030, and Imsidolimab. It also offers SHM platform that replicate the natural process of somatic hypermutation embedded within the human immune system to rapidly develop a diverse range of therapeutic-grade antibodies in vitro. The company was founded by Andrew B. Cubitt, William J. Boyle, Kevin J. Kinsella, and Nicholas B. Lydon in November 2005 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
RENTON HOLLINGSDirectorJun 18 '24Sale23.161,95045,1621,950Jun 18 08:15 PM
Jain RitaDirectorJun 15 '24Option Exercise0.004,53404,534Jun 18 08:14 PM
RENTON HOLLINGSDirectorJun 15 '24Option Exercise0.003,90003,900Jun 18 08:15 PM
Ware J. AnthonyDirectorJun 15 '24Option Exercise0.003,90007,500Jun 18 08:16 PM
Orwin John ADirectorJun 15 '24Option Exercise0.002,03502,035Jun 18 08:15 PM
12345678910